You Position: Home > Paper

Research progress of mitochondrial dysfunction and hypertrophic cardiomyopathy caused by GTPBP3 gene mutation

( views:2, downloads:0 )
Author:
No author available
Journal Title:
Chinese Heart Journal
Issue:
4
DOI:
10.12125/j.chj.202212029
Key Word:
GTPBP3基因;肥厚型心肌病;联合氧化磷酸化缺陷23型;线粒体病;GTPBP3 gene;hypertrophic cardiomyopathy;combined oxidative phosphorylation deficiency 23;mitochondrial disease

Abstract: GTP binding protein 3(GTPBP3)is a highly conserved tRNA modifying enzyme.Mutations in GTPBP3 can affect the fidelity and efficiency of mitochondrial translation by causing defects during post-transcriptional modification of mitochondrial tRNAs,which leads the mitochondrial oxidative respiratory chain dysfunction and then triggers the rare Combined Oxidative Phosphorylation Deficiency 23(COXPD23)with hypertrophic cardiomyopathy,encephalopathy and lactic acidosis as the main manifestations.With the increased use of genetic test in the diagnosis of difficult and rare diseases,papers on mitochondrial diseases characterized primarily by cardiac hypertrophy due to GTPBP3 gene have emerged in recent years.This review provides an overview of recent advances in functional and clinical research on GTPBP3,that may lead to better understanding of the GTPBP3 associated mitochondrial disease.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn
Baidu
map